2014 SABCS Public Friday
Read More`San Antonio, TX - SABCS 2014 San Antonio Breast Cancer Symposium - Rimawi MF discusses "S6-02. TBCRC023: A randomized multicenter phase II neoadjuvant trial of lapatinib plus trastuzumab, with endcorine therapy and without chemotherapy, for 12 vs. 24 weeks in patients with HER2 overexpressing breast cancer " during General Session 6 here today, Friday December 12, 2014. during the San Antonio Breast Cancer Symposium being held at the Henry B. Gonzalez Convention Center in San Antonio, TX. Over 7,500 physicians, researchers, patient advocates and healthcare professionals from over 90 countries attended the meeting which features the latest research on breast cancer treatment and prevention. Photo by © MedMeetingImages/Todd Buchanan 2014 Technical Questions: todd@medmeetingimages.com
Please Contact Sharon Hill, Symposia Director for any use other than editorial use.
Please include photo credit with photo:
"Photo Courtesy © SABCS/Todd Buchanan 2019"